Mon 6 Sep 2021
On-demand
On-demand: featuring presentation and speaker Q&A: sponsored by Abbott this crucial webinar is designed to develop your knowledge of how the technology can improve your patients’ experience of Flash Glucose Monitoring.
A full list of all upcoming Diabetes events can also be viewed at the official Diabetes National Networking Forum website.
On-demand
1 hour CPD
Free
Designed to cement your learning and enhance your knowledge
This crucial webinar is designed to provide real-world learning and enhance your knowledge of how Flash Glucose Monitoring can impact on the lives of people with Type 1 Diabetes plus answer your questions on:
Support and guidance for you in your own time
Packed with engaging examples that will help and inspire you, plus benefit from:
|
1 hour video | Filmed on Monday 6th September 2021 | featuring:
|
|
|
Sofa chat: Patient experience of Flash Glucose Monitoring
Laura Yates, Person with Type 1 Diabetes will join Ramzi Ajjan, Professor of Metabolic Medicine, University of Leeds for a detailed discussion
|
|
|
Questions and answers with the speakers
Ramzi Ajjan, Professor of Metabolic Medicine, University of Leeds will address your questions with Laura Yates, Person with Type 1 Diabetes
|
|
|
Close of webinar
|
First-hand speaker experience
Job Title:
Professor of Metabolic Medicine
Organisation
University of Leeds
Biography
Professor Ajjan (MD, FRCP, MMed.Sci, PhD) obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals Trust. Professor Ajjan’s research work covers a spectrum of basic, translational and clinical studies with the common aim of reducing vascular complications in diabetes and reducing morbidity and mortality in this high-risk population. His research group described three novel mechanisms for hypofibrinolysis in diabetes, with both hypo and hyperglycaemia having key roles. Moreover, Professor Ajjan has shown a close relationship between hypoglycaemia and adverse clinical outcome in patients with diabetes.
Given the pathogenic effects of high and low blood glucose levels, he has been involved in a number of studies investigating the role of continuous glucose monitoring in optimising glycaemic control in diabetes. Professor Ajjan’s research work has been published in peer reviewed journals and he has over 100 publications including original papers, reviews and book chapters.
His clinical practice concentrates on complicated type 2 diabetes patients with established cardiovascular disease as well as young adults with diabetes. Professor Ajjan is the R&D lead for Diabetes/Endocrinology at Leeds Teaching Hospitals Trust and the regional clinical research network lead for endocrine and metabolic conditions. He is also the lead for first year medical student teaching in Endocrinology and Diabetes at Leeds University and co-lead of the Atherothrombosis and Diabetes group within Leeds Institute for Cardiovascular and Metabolic Medicine.